Reinfections with Different SARS-CoV-2 Omicron Subvariants, France

We describe 188 patients in France who were successively infected with different SARS-CoV-2 Omicron subvariants, including BA.1, BA.2, and BA.5. Time between 2 infections was <90 days for 50 (26.6%) patients and <60 days for 28 (14.9%) patients. This finding suggests that definitions for SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Nhu Ngoc, Houhamdi, Linda, Delorme, Léa, Colson, Philippe, Gautret, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622229/
https://www.ncbi.nlm.nih.gov/pubmed/36150518
http://dx.doi.org/10.3201/eid2811.221109
_version_ 1784821714113265664
author Nguyen, Nhu Ngoc
Houhamdi, Linda
Delorme, Léa
Colson, Philippe
Gautret, Philippe
author_facet Nguyen, Nhu Ngoc
Houhamdi, Linda
Delorme, Léa
Colson, Philippe
Gautret, Philippe
author_sort Nguyen, Nhu Ngoc
collection PubMed
description We describe 188 patients in France who were successively infected with different SARS-CoV-2 Omicron subvariants, including BA.1, BA.2, and BA.5. Time between 2 infections was <90 days for 50 (26.6%) patients and <60 days for 28 (14.9%) patients. This finding suggests that definitions for SARS-CoV-2 reinfection require revision.
format Online
Article
Text
id pubmed-9622229
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-96222292022-11-05 Reinfections with Different SARS-CoV-2 Omicron Subvariants, France Nguyen, Nhu Ngoc Houhamdi, Linda Delorme, Léa Colson, Philippe Gautret, Philippe Emerg Infect Dis Research Letter We describe 188 patients in France who were successively infected with different SARS-CoV-2 Omicron subvariants, including BA.1, BA.2, and BA.5. Time between 2 infections was <90 days for 50 (26.6%) patients and <60 days for 28 (14.9%) patients. This finding suggests that definitions for SARS-CoV-2 reinfection require revision. Centers for Disease Control and Prevention 2022-11 /pmc/articles/PMC9622229/ /pubmed/36150518 http://dx.doi.org/10.3201/eid2811.221109 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Nguyen, Nhu Ngoc
Houhamdi, Linda
Delorme, Léa
Colson, Philippe
Gautret, Philippe
Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
title Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
title_full Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
title_fullStr Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
title_full_unstemmed Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
title_short Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
title_sort reinfections with different sars-cov-2 omicron subvariants, france
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622229/
https://www.ncbi.nlm.nih.gov/pubmed/36150518
http://dx.doi.org/10.3201/eid2811.221109
work_keys_str_mv AT nguyennhungoc reinfectionswithdifferentsarscov2omicronsubvariantsfrance
AT houhamdilinda reinfectionswithdifferentsarscov2omicronsubvariantsfrance
AT delormelea reinfectionswithdifferentsarscov2omicronsubvariantsfrance
AT colsonphilippe reinfectionswithdifferentsarscov2omicronsubvariantsfrance
AT gautretphilippe reinfectionswithdifferentsarscov2omicronsubvariantsfrance

Ejemplares similares